Yuqiang Shan
Overview
Explore the profile of Yuqiang Shan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lv C, Chen T, Li J, Shan Y, Zhou H
Cancer Immunol Immunother
. 2025 Feb;
74(3):102.
PMID: 39904894
Background: The advent of immunotherapy has revolutionized the treatment paradigm for gastric cancer (GC), offering unprecedented clinical benefits. However, a detailed molecular characterization of the tumor immune microenvironment in GC...
2.
Shan Y, Li J, Zhu A, Kong W, Ying R, Zhu W
Int J Mol Med
. 2024 Nov;
55(1).
PMID: 39513590
Following the publication of this paper, it was drawn to the Editor's attention by a concerned reader that certain of the flow cytometric data shown in Fig. 1D, DCFH‑DA‑stained cellular...
3.
Shi J, Yang Y, Chen F, Zhou L, Wei H, Dong F, et al.
Transl Oncol
. 2024 Nov;
51:102170.
PMID: 39489085
Ribosomal protein L36A (RPL36A) was one of the most upregulated proteins in colorectal cancer (CRC), yet its role in colorectal cancer (CRC) remains largely unexplored, with limited studies investigating its...
4.
Kong W, Liu X, Zhu H, Zheng S, Yin G, Yu P, et al.
Aging (Albany NY)
. 2024 Jan;
16(2):1767-1780.
PMID: 38244583
Approximately 10% of gastric cancers are associated with Epstein-Barr virus (EBV). polysaccharides (TFPs) are characterized by antioxidative and anti-inflammatory effects in different diseases. However, whether TFP improves EBV-associated gastric cancer...
5.
Yin G, Kong W, Zheng S, Shan Y, Zhang J, Ying R, et al.
Oncol Lett
. 2023 Sep;
26(4):430.
PMID: 37664654
[This retracts the article DOI: 10.3892/ol.2021.12544.].
6.
Wang L, Shan Y, Zheng S, Li J, Cui P
Stem Cells Int
. 2023 Aug;
2023:2759679.
PMID: 37576407
Despite significant advances in diagnostic methods and treatment strategies, the prognosis for patients with advanced colon cancer remains poor, and mortality rates are often high due to metastasis. Increasing evidence...
7.
Liu X, Kong W, Ying R, Shan Y, Yin G
Heliyon
. 2023 Jun;
9(6):e17272.
PMID: 37360094
Duodenal stump fistula is a rare but dangerous complication of gastric cancer surgery. Reinforcement of the duodenal stump was suggested as a useful method to prevent the occurrence of duodenal...
8.
Kong W, Zhu H, Zheng S, Yin G, Yu P, Shan Y, et al.
J Cell Mol Med
. 2022 Oct;
26(21):5539-5550.
PMID: 36251949
Larotrectinib (Lar) is a highly selective and potent small-molecule inhibitor used in patients with tropomyosin receptor kinase (TRK) fusion-positive cancers, including colon cancer. However, the underlying molecular mechanisms specifically in...
9.
Long noncoding RNA (lncRNA) HOTAIR: Pathogenic roles and therapeutic opportunities in gastric cancer
Kong W, Yin G, Zheng S, Liu X, Zhu A, Yu P, et al.
Genes Dis
. 2022 Jul;
9(5):1269-1280.
PMID: 35873034
Gastric cancer is one of the first malignant cancers in the world and a large number of people die every year due to this disease. Many genetic and epigenetic risk...
10.
Shan Y, Kong W, Zhu A, Li J, Jin H, Zhu W
Cell Mol Biol (Noisy-le-grand)
. 2022 Jul;
67(4):83-90.
PMID: 35809300
Nowadays, pancreatic cancer has been recognized as one of the most fatal malignancies worldwide, the molecular mechanism of which is still not fully understood. In this study, we aimed to...